|Articles|September 27, 2006
Celsis Acquires In Vitro Technologies, Expanding Services for ADME Studies
Author(s)BioPharm International Editors
Celsis International plc (Chicago, IL, www.celsis.com) has acquired In Vitro Technologies, Inc. (Baltimore, MD, www.invitrotech.com).
Advertisement
Celsis International plc (Chicago, IL,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
